Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Clinical trial NCT00227032 · TERMINATED

Trial details

NCT number: NCT00227032
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2005-09-01
Primary completion: 2008-02-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.